Hepatology highlights^†

• Pages: 1-3
• First Published: 16 June 2005

Milk thistle and chronic liver disease^†

• Page: 4
• First Published: 16 June 2005

Steatosis: Co-factor in other liver diseases^†

• Pages: 5-13
• First Published: 16 June 2005

Diagnosis of small hepatocellular carcinoma^{† ‡}

• Pages: 14-16
• First Published: 16 June 2005

Of mice and women: Toward a mouse model of autoimmune hepatitis^{† ‡}

• Pages: 17-20
• First Published: 16 June 2005

A novel target of hepatitis B virus mutations: Splicing of surface RNA^{† ‡}

• Pages: 21-23
• First Published: 16 June 2005

Methodological issues and the measurement of fatigue in primary biliary cirrhosis^{† ‡}

• Pages: 24-26
• First Published: 16 June 2005

Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma^†

• Pages: 27-34
• First Published: 13 June 2005

Male cell microchimerism in normal and diseased female livers from fetal life to adulthood^†

• Pages: 35-43
• First Published: 16 June 2005

Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study^†‡

• Pages: 44-52
• First Published: 13 May 2005

Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome^†

• Pages: 53-62
• First Published: 13 June 2005

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C^†

• Pages: 63-71
• First Published: 12 May 2005

A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A^†

• Pages: 72-76
• First Published: 25 May 2005

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative^†

• Pages: 77-85
• First Published: 16 June 2005

Viral and host factors in early hepatitis C virus infection^†

• Pages: 86-92
• First Published: 13 June 2005

Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals^†

• Pages: 93-103
• First Published: 16 June 2005

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C^†

• Pages: 104-112
• First Published: 16 June 2005

The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum^†

• Pages: 113-120
• First Published: 26 May 2005

Outcome of hepatitis B e antigen–negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine^†

• Pages: 121-129
• First Published: 16 June 2005

Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity^†

• Pages: 130-139
• First Published: 13 May 2005

Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice^†

• Pages: 140-148
• First Published: 25 May 2005

A murine model of acute liver injury induced by human monoclonal autoantibody^†

• Pages: 149-155
• First Published: 25 May 2005

A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21^waf1-dependent mechanism^†

• Pages: 156-164
• First Published: 16 June 2005

Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model^†

• Pages: 165-175
• First Published: 16 June 2005

Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity^†

• Pages: 176-182
• First Published: 16 June 2005

Transforming growth factor β can mediate apoptosis via the expression of TRAIL in human hepatoma cells^†

• Pages: 183-192
• First Published: 16 June 2005

Murine liver antigen presenting cells control suppressor activity of CD4⁺CD25⁺ regulatory T cells^†

• Pages: 193-199
• First Published: 16 June 2005

Cytoplasmic retention of peroxide-activated ERK provides survival in primary cultures of rat hepatocytes^†

• Pages: 200-207
• First Published: 16 June 2005

Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: Role of TNF-α^†

• Pages: 208-215
• First Published: 16 June 2005

Activation and function of hepatocyte NF-κB in postischemic liver injury^†

• Pages: 216-218
• First Published: 16 June 2005

Is the FXR the fix for cholesterol gallstone disease?^†

• Pages: 218-221
• First Published: 16 June 2005

Intrahepatic cholestasis: Summary of an American Association for the Study of Liver Diseases single-topic conference^†

• Pages: 222-235
• First Published: 16 May 2005

Influence of tips on development of hepatocellular carcinoma in cirrhosis^†

• Page: 236
• First Published: 12 May 2005

Reply:^†

• Pages: 236-237
• First Published: 16 June 2005

Safety of short-term administration of celecoxib in decompensated cirrhosis^†

• Page: 237
• First Published: 12 May 2005

Reply:^†

• Page: 238
• First Published: 01 June 2005

Comparison of staging systems for HCC: One more positive answer or mission impossible?^†

• Pages: 238-239
• First Published: 16 June 2005

Reactivation of viral replication after replacement of tenofovir by adefovir^†

• Pages: 239-240
• First Published: 16 June 2005

TIPS for veno-occlusive disease: Is the contraindication real?^†

• Pages: 240-241
• First Published: 16 June 2005

Reply:^†

• Page: 241
• First Published: 16 June 2005

• Page: 242
• First Published: 16 June 2005